Search research articles
Contact Us
Filters
Showing results (11-20 of 204) with videos related to
Page
of 21
Sort By:
Molecular and Cellular Endocrinology
|
February 8, 2003
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease
Fernand Labrie
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 15, 2005
Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility
Fernand Labrie
Nature Clinical Practice. Endocrinology & Metabolism
|
July 24, 2007
Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy
Fernand Labrie
The Journal of Steroid Biochemistry and Molecular Biology
|
June 14, 2014
All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause
Fernand Labrie
Endocrine-Related Cancer
|
May 15, 2014
GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer
Fernand Labrie
European Journal of Endocrinology
|
July 14, 2004
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
André Tchernof, Fernand Labrie
Hormone Molecular Biology and Clinical Investigation
|
December 21, 2016
A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values
Fernand Labrie, Céline Martel
Progress in Brain Research
|
May 19, 2010
The intracrine sex steroid biosynthesis pathways
Van Luu-The, Fernand Labrie
Menopause (New York, N.Y.)
|
August 5, 2010
Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
Fernand Labrie, Céline Martel, John Balser
Menopause (New York, N.Y.)
|
November 23, 2016
Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
Fernand Labrie, Céline Martel, Georges Pelletier
Page
of 21
Search research articles
Search
Showing results (11-20 of 204) with videos related to
Sort By:
Page
of 21
Molecular and Cellular Endocrinology
|
February 8, 2003
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease
Fernand Labrie
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 15, 2005
Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility
Fernand Labrie
Nature Clinical Practice. Endocrinology & Metabolism
|
July 24, 2007
Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy
Fernand Labrie
The Journal of Steroid Biochemistry and Molecular Biology
|
June 14, 2014
All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause
Fernand Labrie
Endocrine-Related Cancer
|
May 15, 2014
GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer
Fernand Labrie
European Journal of Endocrinology
|
July 14, 2004
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
André Tchernof, Fernand Labrie
Hormone Molecular Biology and Clinical Investigation
|
December 21, 2016
A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values
Fernand Labrie, Céline Martel
Progress in Brain Research
|
May 19, 2010
The intracrine sex steroid biosynthesis pathways
Van Luu-The, Fernand Labrie
Menopause (New York, N.Y.)
|
August 5, 2010
Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
Fernand Labrie, Céline Martel, John Balser
Menopause (New York, N.Y.)
|
November 23, 2016
Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
Fernand Labrie, Céline Martel, Georges Pelletier
Page
of 21